VISN
CommScope Holding Company, Inc.NASDAQTECHNOLOGYCOMMUNICATION EQUIPMENT
Key Statistics
Market Cap
$2.69B
P/E Ratio
17.54
EPS
$0.68
Beta
2.38
52W High
$13.22
52W Low
$2.31
50-Day MA
$17.72
200-Day MA
$16.73
Dividend Yield
0.00%
Profit Margin
347.70%
Forward P/E
3.72
PEG Ratio
2.94
About CommScope Holding Company, Inc.
Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company, develops gene therapy products to treat patients with eye diseases. The company is headquartered in Stevenage, the United Kingdom.
Fundamentals
| Revenue (TTM) | $2.02B |
| Gross Profit (TTM) | $992.00M |
| EBITDA | $384.00M |
| Operating Margin | 7.50% |
| Return on Equity | 13.10% |
| Return on Assets | 1.41% |
| Revenue/Share (TTM) | $9.09 |
| Book Value | $20.37 |
| Price-to-Book | 0.59 |
| Price-to-Sales (TTM) | 1.33 |
| EV/Revenue | 0.0965 |
| EV/EBITDA | 0.62 |
| Quarterly Earnings Growth (YoY) | 704.00% |
| Quarterly Revenue Growth (YoY) | -57.60% |
| Shares Outstanding | $225.51M |
| Float | $217.50M |
| % Insiders | 3.37% |
| % Institutions | 90.26% |
Historical Volatility
HV 10-Day
17.88%
HV 20-Day
23.18%
HV 30-Day
24.93%
HV 60-Day
32.27%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($19.33 target)
1
Buy3
HoldMore TECHNOLOGY Stocks
Data last updated: 5/5/2026